Rapid Dose Therapeutics

Canada
Burlington, Ontario, Canada

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Total equity funding
$1.2M
Last funding
Post IPO Equity / $965,574 / 2024-01-20
Last equity funding
Post IPO Equity / $965,574
Founders
1
Articles
36
Exited on
2018-12-17

Founders and investors

Founders

Mark Upsdell